{
  "main_header": {
    "sid": 493236,
    "name": "Genomic Valley",
    "stock_name": "Genomic Valley",
    "full_name": "Genomic Valley Biotech Ltd",
    "name_url": "stocks-analysis/genomic-valley",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "23.40",
    "chg": 0.95,
    "chgp": "4.23%",
    "dir": 1,
    "prev_price": "22.45",
    "mcapval": "7.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539206,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 67,
    "indexname": "",
    "isin": "INE574D01010",
    "curr_date": "Dec 22",
    "curr_time": "",
    "bse_nse_vol": "606 ",
    "exc_status": "Active",
    "traded_date": "Dec 22, 2025",
    "traded_date_str": "2025 12 22",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/genomic-valley-493236-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Genomic Valley?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-genomic-valley-3623995",
        "imagepath": "",
        "date": "2025-10-15 22:43:37",
        "description": "Answer:\nThe historical performance of Genomic Valley shows significant fluctuations in its financial metrics over the years.\n\nBreakdown:\nGenomic Valley's net sales have varied considerably, peaking at 2.72 Cr in Mar'23 before dropping to 0.84 Cr in Mar'25. The total operating income followed a similar trend, with a high of 2.72 Cr in Mar'23 and a decrease to 0.84 Cr in Mar'25. The company experienced an operating profit (PBDIT) of 0.43 Cr in Mar'25, a recovery from a loss of -0.30 Cr in Mar'22, indicating improved operational efficiency. Profit before tax also showed a positive trend, reaching 0.44 Cr in Mar'25, while profit after tax was 0.36 Cr in the same period, up from a loss of -0.01 Cr in Mar'22. The operating profit margin improved significantly to 51.19% in Mar'25, reflecting better cost management. Total liabilities decreased to 4.33 Cr in Mar'24 from 7.61 Cr in Mar'21, and total assets also decli..."
      },
      {
        "title": "When is the next results date for Genomic Valley?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-genomic-valley-3605127",
        "imagepath": "",
        "date": "2025-10-08 23:16:07",
        "description": "The next results date for Genomic Valley is scheduled for 15 October 2025...."
      }
    ],
    "total": 12,
    "sid": "493236",
    "stock_news_url": "https://www.marketsmojo.com/news/genomic-valley-biotech-493236"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "10-Dec-2025",
      "details": "Please find enclosed herewith Newspaper intimation for the 31st Annual General Meeting for your reference.",
      "source": "BSE"
    },
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "09-Dec-2025",
      "details": "Compliance Under Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015- Annual Report for The Financial Year 2024-25",
      "source": "BSE"
    },
    {
      "caption": "Notice Of The Annual General Meeting",
      "datetime": "09-Dec-2025",
      "details": "Please find enclosed herewith the Notice of the Annual General Meeting for your reference.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

How has been the historical performance of Genomic Valley?

2025-10-15 22:43:37

Answer: The historical performance of Genomic Valley shows significant fluctuations in its financial metrics over the years. Breakdown: Genomic Valley's net sales have varied considerably, peaking at 2.72 Cr in Mar'23 before dropping to 0.84 Cr in Mar'25. The total operating income followed a similar trend, with a high of 2.72 Cr in Mar'23 and a decrease to 0.84 Cr in Mar'25. The company experienced an operating profit (PBDIT) of 0.43 Cr in Mar'25, a recovery from a loss of -0.30 Cr in Mar'22, indicating improved operational efficiency. Profit before tax also showed a positive trend, reaching 0.44 Cr in Mar'25, while profit after tax was 0.36 Cr in the same period, up from a loss of -0.01 Cr in Mar'22. The operating profit margin improved significantly to 51.19% in Mar'25, reflecting better cost management. Total liabilities decreased to 4.33 Cr in Mar'24 from 7.61 Cr in Mar'21, and total assets also decli...

Read More

When is the next results date for Genomic Valley?

2025-10-08 23:16:07

The next results date for Genomic Valley is scheduled for 15 October 2025....

Read More

View All News